Stock listing

JANX Stock Price, News, Filings & Events — Janux Therapeutics, Inc.

Selected listing: JANX · BX · CHF · CH

This page tracks Janux Therapeutics, Inc.'s JANX:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JANX:BX. JANX:BX is the stock-level entry point for investors researching Janux Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Janux Therapeutics, Inc. is a public company traded under the ticker JANX in the American market. The company has a market capitalization of approximately $934.9 million. Janux focuses on developing innovative therapies to address unmet medical needs in cancer treatment.